Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Iran Introduces Anticancer Nano Drug to Market

A nanoliposomal drug containing the anticancer agent, doxorubicin, was introduced to the Iranian market with the brand name of Sina Doxosome on Tuesday.

Iran Introduces Anticancer Nano Drug to Market

Tehran, Iran | Posted on July 3rd, 2012

The drug, with its exclusive production rights belonging to a number of European countries and the US, used to be sold at high prices under the trademark names of Caelyx® and Doxil® over a long period. Thanks to the efforts made by the Iranian researchers at a knowledge-based company, the technology for mass-production of the nano-based drug has been localized and is available within the national market.

"Today, after establishment of the production line and taking all the regulatory steps for securing the necessary approvals, about 200 vials of the drug have been delivered to the distribution network," Dr. Seyed Mehdi Rezayat, the head of Human Resources Development Workgroup of the Iran Nanotechnology Initiative Council (INIC) and the director of the project, pointed out.

Sina Doxosome® contains doxorubicin (antitumor) loaded nano liposomes which identify and attack tumor tissues through a targeted drug delivery mechanism. As a result, this drug can effectively help the treatment of ovarian, breast and blood cancers as well as kaposi sarcoma (a type of soft tissue cancer) with remarkably reduced side effects.

"Regarding the incentive support policies of INIC and the admirable efforts made by a number of knowledge-based companies working on health care issues (in close connection with The Food and Drug organization of the Ministry of Health), we hope to have new products on the shelves by the end of this year. Hopefully, at least one of these products will be a nano drug, as a gift of nanotechnology, to improve the health quality of our fellow countrymen," Dr. Rezayat told INIC's website, elaborating on the INIC's future plans for production of nano-based drugs.

The production line of the anticancer Sina Doxosome drug was launched in February 2012 in Sobhan Oncology Co. In addition to meet the domestic demands, the company plans to fully benefit from export market opportunities. The mentioned nano drug has received all the mandatory approvals from Iran's Ministry of Health and Medical Education last year.


For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Unraveling the crystal structure of a -70° Celsius superconductor, a world first: Significant advancement in the realization of room-temperature superconductors August 25th, 2016

Stretchy supercapacitors power wearable electronics August 25th, 2016

AIM Photonics Announces Release of Process Design Kit (PDK) for Integrated Silicon Photonics Design August 25th, 2016

Semblant to Present at China Mobile Manufacturing Forum 2016 August 25th, 2016


Nanofiber scaffolds demonstrate new features in the behavior of stem and cancer cells August 25th, 2016

Johns Hopkins scientists track metabolic pathways to find drug combination for pancreatic cancer August 25th, 2016

50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016

Tunneling nanotubes between neurons enable the spread of Parkinson's disease via lysosomes August 24th, 2016


Analog DNA circuit does math in a test tube: DNA computers could one day be programmed to diagnose and treat disease August 25th, 2016

Silicon nanoparticles trained to juggle light: Research findings prove the capabilities of silicon nanoparticles for flexible data processing in optical communication systems August 25th, 2016

Johns Hopkins scientists track metabolic pathways to find drug combination for pancreatic cancer August 25th, 2016

New electrical energy storage material shows its power: Nanomaterial combines attributes of both batteries and supercapacitors August 25th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic